Page last updated: 2024-09-02

norbuprenorphine and Neonatal Abstinence Syndrome

norbuprenorphine has been researched along with Neonatal Abstinence Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Berquist, MD; Brents, LK; Coward, LU; Gorman, GS; Parks, BJ; Salazar, P; Tobacyk, J1
Adeniyi-Jones, SC; Ehrlich, ME; Fang, WB; Gastonguay, MR; Kraft, WK; Moody, DE; Moore, JN; Ng, CM1

Trials

1 trial(s) available for norbuprenorphine and Neonatal Abstinence Syndrome

ArticleYear
The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome.
    Clinical pharmacology and therapeutics, 2018, Volume: 103, Issue:6

    Topics: Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Male; Metabolic Clearance Rate; Morphine; Neonatal Abstinence Syndrome; Respiratory Rate

2018

Other Studies

1 other study(ies) available for norbuprenorphine and Neonatal Abstinence Syndrome

ArticleYear
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
    Drug and alcohol dependence, 2023, 08-01, Volume: 249

    Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Rats; Rats, Long-Evans; Receptors, Opioid, mu

2023